(Q43590292)

25 November 2017

title

Reirradiation of primary brain tumours: survival, clinical response and prognostic factors (English)

1 reference

25 November 2017

3

1 reference

25 November 2017

Veninga T

1

1 reference

25 November 2017

Langendijk HA

2

1 reference

25 November 2017

Rutten EH

4

1 reference

25 November 2017

van der Kogel AJ

5

1 reference

25 November 2017

Prick MJ

6

1 reference

25 November 2017

Keyser A

7

1 reference

25 November 2017

van der Maazen RW

8

1 reference

25 November 2017

publication date

1 May 2001

1 reference

Radiotherapy and Oncology

25 November 2017

published in

1 reference

25 November 2017

volume

59

1 reference

25 November 2017

issue

2

1 reference

25 November 2017

page(s)

127-137

1 reference

Reoperation in the treatment of recurrent intracranial malignant gliomas

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900299-7

7 January 2021

The tolerance of primate spinal cord to re-irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900299-7

7 January 2021

Reirradiation and lomustine in patients with relapsed high-grade gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900299-7

7 January 2021

Reirradiation of primary CNS tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900299-7

7 January 2021

The morphologic effects of radiation administered therapeutically for intracranial gliomas.A Postmortem study of 25 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900299-7

7 January 2021

Single dose versus fractionated stereotactic radiotherapy for recurrent high-grade gliomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900299-7

7 January 2021

Cerebral metastases: value of reirradiation in selected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900299-7

7 January 2021

Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900299-7

7 January 2021

Grading of astrocytomas. A simple and reproducible method.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900299-7

7 January 2021

The linear-quadratic formula and progress in fractionated radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900299-7

7 January 2021

Reoperation for recurrent glioblastoma and anaplastic astrocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900299-7

7 January 2021

Brain metastases: results and effects of re-irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900299-7

7 January 2021

A phase I dose escalation study of hypofractionated stereotactic radiotherapy as salvage therapy for persistent or recurrent malignant glioma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900299-7

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900299-7

7 January 2021

The new WHO classification of brain tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900299-7

7 January 2021

Survival and quality of life after interstitial implantation of removable high-activity iodine-125 sources for the treatment of patients with recurrent malignant gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900299-7

7 January 2021

Accelerated hyperfractionated radiotherapy in 149 patients with glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900299-7

7 January 2021

Response criteria for phase II studies of supratentorial malignant glioma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900299-7

7 January 2021

Cerebral radionecrosis: Incidence and risk in relation to dose, time, fractionation and volume

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900299-7

7 January 2021

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900299-7

7 January 2021

Radiation therapy for malignant astrocytomas in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900299-7

7 January 2021

3D-recurrence-patterns of glioblastomas after CT-planned postoperative irradiation.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900299-7

7 January 2021

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900299-7

7 January 2021

Multivariate analysis of prognostic factors in 106 patients with malignant glioma.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900299-7

7 January 2021

Radiation myelopathy in primates treated with conventional fractionation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900299-7

7 January 2021

Radiation response of the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900299-7

7 January 2021

Therapeutic irradiation and brain injury

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900299-7

7 January 2021

Hypofractionated stereotactic radiotherapy in the management of recurrent glioma.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900299-7

7 January 2021

Intraoperative radiation therapy for brain tumors with emphasis on retreatment for recurrence following full-dose external beam irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900299-7

7 January 2021

Reirradiation for recurrent cerebral astrocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900299-7

7 January 2021

Grading of oligodendrogliomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900299-7

7 January 2021

Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900299-7

7 January 2021

Analysis of outcome in patients reirradiated for brain metastases.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900299-7

7 January 2021

The prognostic importance of tumor size in malignant gliomas: a computed tomographic scan study by the Brain Tumor Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900299-7

7 January 2021

Reoperation for glioblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900299-7

7 January 2021

10.1016/S0167-8140(01)00299-7

Identifiers

DOI

1 reference

25 November 2017

1 reference